65 related articles for article (PubMed ID: 21813410)
21. Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients.
Gutierrez JC; Fischer AC; Sola JE; Perez EA; Koniaris LG
Pediatr Surg Int; 2007 Jul; 23(7):637-46. PubMed ID: 17476512
[TBL] [Abstract][Full Text] [Related]
22. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.
Singer RB
J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138
[TBL] [Abstract][Full Text] [Related]
23. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project.
Spix C; Pastore G; Sankila R; Stiller CA; Steliarova-Foucher E
Eur J Cancer; 2006 Sep; 42(13):2081-91. PubMed ID: 16919772
[TBL] [Abstract][Full Text] [Related]
24. Screening of infants and mortality due to neuroblastoma.
Woods WG; Gao RN; Shuster JJ; Robison LL; Bernstein M; Weitzman S; Bunin G; Levy I; Brossard J; Dougherty G; Tuchman M; Lemieux B
N Engl J Med; 2002 Apr; 346(14):1041-6. PubMed ID: 11932470
[TBL] [Abstract][Full Text] [Related]
25. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
[TBL] [Abstract][Full Text] [Related]
26. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
Oberthuer A; Berthold F; Warnat P; Hero B; Kahlert Y; Spitz R; Ernestus K; König R; Haas S; Eils R; Schwab M; Brors B; Westermann F; Fischer M
J Clin Oncol; 2006 Nov; 24(31):5070-8. PubMed ID: 17075126
[TBL] [Abstract][Full Text] [Related]
27. Myelodysplastic syndromes: incidence and survival in the United States.
Ma X; Does M; Raza A; Mayne ST
Cancer; 2007 Apr; 109(8):1536-42. PubMed ID: 17345612
[TBL] [Abstract][Full Text] [Related]
28. Trends in leukemia incidence and survival in the United States (1973-1998).
Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
[TBL] [Abstract][Full Text] [Related]
29. StatBite: Mesothelioma incidence among U.S. men.
J Natl Cancer Inst; 2007 Dec; 99(23):1751. PubMed ID: 18042928
[No Abstract] [Full Text] [Related]
30. StatBite: SEER incidence of brain and other nervous system cancers 1992-2007.
J Natl Cancer Inst; 2010 Jul; 102(13):930. PubMed ID: 20581333
[No Abstract] [Full Text] [Related]
31. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
33. Neuroblastoma in adolescents: the Italian experience.
Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
[TBL] [Abstract][Full Text] [Related]
34. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.
El-Serag HB; Mason AC; Key C
Hepatology; 2001 Jan; 33(1):62-5. PubMed ID: 11124821
[TBL] [Abstract][Full Text] [Related]
35. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
Mora J; Cheung NK; Chen L; Qin J; Gerald W
Cancer; 2001 Jan; 91(2):435-42. PubMed ID: 11180092
[TBL] [Abstract][Full Text] [Related]
36. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database.
Rosenberg J; Chia YL; Plevritis S
Breast Cancer Res Treat; 2005 Jan; 89(1):47-54. PubMed ID: 15666196
[TBL] [Abstract][Full Text] [Related]
37. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
38. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O;
Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
[TBL] [Abstract][Full Text] [Related]
39. Cancer in neonates and infants.
Vasilatou-Kosmidis H
Med Pediatr Oncol; 2003 Jul; 41(1):7-9. PubMed ID: 12764735
[No Abstract] [Full Text] [Related]
40. Stat bite: U.S. incidence of childhood Hodgkin lymphoma by age group, 1975-2002.
J Natl Cancer Inst; 2006 Jan; 98(1):7. PubMed ID: 16391364
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
